Top Markets
Coin of the day
Lattice Biologics Ltd. Lattice Biologics Ltd.

Lattice Biologics Ltd.

LBLTF
Rang in aandelen #41553
Lattice Biologics Ltd. is a biotechnology firm focused on developing,... Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$16.55K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Lattice Biologics Ltd. (LBLTF)

Categorie

EPS voor Lattice Biologics Ltd. (LBLTF)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Lattice Biologics Ltd. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Lattice Biologics Ltd. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten